Garuda Therapeutics

Garuda Therapeutics is developing off-the-shelf, long-lasting hematopoietic stem cell (HSC) therapies to treat a variety of severe and life-threatening diseases. Garuda was founded and is supported by experts in hematopoietic stem cell and bone marrow transplantation as well as leaders with expertise in delivering transformative medicines to patients. The company is committed to eliminating the reliance on donor or patient cells for blood stem cell transplants. Our platform technology for generating off-the-shelf, self-renewing blood stem cells holds the potential to provide patients with rapid, broad access to HLA-compatible, non-genetically modified blood stem cell therapies. Like bone marrow transplantation, our technology can offer potential treatments for more than 70 diseases.